Kemnay Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.1K Buy
89
+1
+1% +$329 ﹤0.01% 515
2025
Q4
$30.8K Buy
+88
New +$29.7K ﹤0.01% 418
2021
Q3
Sell
-2,041
Closed -$779K 94
2021
Q2
$779K Buy
+2,041
New +$780K 0.09% 67
2019
Q2
Sell
-3,818
Closed -$1.1M 101
2019
Q1
$1.1M Sell
3,818
-461
-11% -$133K 0.24% 64
2018
Q4
$1.12M Sell
4,279
-478
-10% -$131K 0.42% 62
2018
Q3
$1.3M Sell
4,757
-594
-11% -$154K 0.4% 57
2018
Q2
$1.27M Sell
5,351
-391
-7% -$90.5K 0.4% 76
2018
Q1
$1.26M Buy
5,742
+19
+0.3% +$4.46K 0.54% 60
2017
Q4
$1.29M Buy
5,723
+1,396
+32% +$297K 0.58% 55
2017
Q3
$822K Buy
4,327
+15
+0.3% +$2.85K 0.35% 28
2017
Q2
$811K Buy
+4,312
New +$775K 0.47% 30

Other funds holding ELV

Kemnay Advisory Services's ELV Position: Q1 2026 in Review

Kemnay Advisory Services increased its Elevance Health (ELV) stake by 1.1% in Q1 2026, buying an estimated $329 and bringing the position to 89 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Kemnay Advisory Services first reported a position in ELV in Q2 2017 and has held it in 11 quarters since. The position peaked at $1.3M in Q3 2018. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Kemnay Advisory Services held 89 shares of Elevance Health worth $26.1K as of Q1 2026.
  • Kemnay Advisory Services bought 1 Elevance Health share in Q1 2026, an estimated $329.
  • Elevance Health made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q1 2026, its #515 holding.
  • Kemnay Advisory Services first reported a position in Elevance Health in Q2 2017 and has held it in 11 quarters since.
  • Kemnay Advisory Services's Elevance Health position peaked at $1.3M in Q3 2018.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.